Patent · US Active

Fused ring heterocycle kinase modulators

US7452993B2 · kind B2 · utility

178Cited by
8References
31Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 27, 2005
Grant dateNov 18, 2008
Priority date
Expiry dateSep 12, 2026

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides novel fused ring heterocycle kinase modulators and methods of using the novel fused ring heterocycle kinase modulators to treat diseases mediated by kinase activity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.